Scrip RSS Feedhttps://insights.citeline.comThe Latest News & Analysis from ScripSat, 18 Apr 2026 09:29:14 +0000en1hourly1 https://insights.citeline.com/scrip/business/legalandip/lupin-follows-sandoz-sun-in-antitrust-suit-settlement-30m-for-humana-XUQC7QPY7NCHHANDFIUT57Z6WQ/<![CDATA[Lupin Follows Sandoz, Sun In Antitrust Suit Settlement; $30m For Humana]]>premium

      
]]> https://feeds.feedblitz.com/~/953952329/0/scrip~Lupin-Follows-Sandoz-Sun-In-Antitrust-Suit-Settlement-m-For-Humana/https://insights.citeline.com/scrip/business/legalandip/lupin-follows-sandoz-sun-in-antitrust-suit-settlement-30m-for-humana-XUQC7QPY7NCHHANDFIUT57Z6WQ/
      
]]> Fri, 17 Apr 2026 13:28:48 +0000 https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-oricell-terremoto-neomorph-raise-venture-mega-rounds-W43TIDO6NZHAXHOJBCU6GR2F3Y/<![CDATA[Finance Watch: Oricell, Terremoto, Neomorph Raise Venture Mega-Rounds]]>premium

      
]]> https://feeds.feedblitz.com/~/953968781/0/scrip~Finance-Watch-Oricell-Terremoto-Neomorph-Raise-Venture-MegaRounds/https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-oricell-terremoto-neomorph-raise-venture-mega-rounds-W43TIDO6NZHAXHOJBCU6GR2F3Y/
      
]]> Fri, 17 Apr 2026 20:49:40 +0000 https://insights.citeline.com/scrip/advanced-therapies/gene-therapies/meiragtx-brings-rare-eye-disease-gene-therapy-back-home-5FSEXSKIGNDJ3NKWYHBNP3GUTE/<![CDATA[MeiraGTx Brings Rare Eye Disease Gene Therapy Back Home]]>premium

      
]]> https://feeds.feedblitz.com/~/953952332/0/scrip~MeiraGTx-Brings-Rare-Eye-Disease-Gene-Therapy-Back-Home/https://insights.citeline.com/scrip/advanced-therapies/gene-therapies/meiragtx-brings-rare-eye-disease-gene-therapy-back-home-5FSEXSKIGNDJ3NKWYHBNP3GUTE/
      
]]> Fri, 17 Apr 2026 13:50:20 +0000 https://insights.citeline.com/scrip/business/deals/deal-watch/ucb-looks-to-bolster-its-epilepsy-pipeline-with-neurona-buyout-Z677AOABDJGG7IKYTKZNPNIVUE/<![CDATA[UCB Looks To Bolster Its Epilepsy Pipeline With Neurona Buyout]]>premium

      
]]> https://feeds.feedblitz.com/~/953967152/0/scrip~UCB-Looks-To-Bolster-Its-Epilepsy-Pipeline-With-Neurona-Buyout/https://insights.citeline.com/scrip/business/deals/deal-watch/ucb-looks-to-bolster-its-epilepsy-pipeline-with-neurona-buyout-Z677AOABDJGG7IKYTKZNPNIVUE/
      
]]> Fri, 17 Apr 2026 20:26:15 +0000 https://insights.citeline.com/scrip/business/financing/kailera-ipo-is-biggest-so-far-in-2026-may-become-biopharmas-largest-in-the-us-EMY324OYS5H4TEBSZJO36RJIBI/<![CDATA[Kailera IPO Is Biggest So Far In 2026, May Become Biopharma’s Largest In The US]]>premium

      
]]> https://feeds.feedblitz.com/~/953969438/0/scrip~Kailera-IPO-Is-Biggest-So-Far-In-May-Become-Biopharma%e2%80%99s-Largest-In-The-US/https://insights.citeline.com/scrip/business/financing/kailera-ipo-is-biggest-so-far-in-2026-may-become-biopharmas-largest-in-the-us-EMY324OYS5H4TEBSZJO36RJIBI/
      
]]> Fri, 17 Apr 2026 21:11:25 +0000 https://insights.citeline.com/scrip/business/supply-chain/prolonged-us-blockade-of-iran-ports-risks-drug-shortages-wider-supply-chain-woes-SEMZ4LNEPVA63KV7XAUFT6VCJY/<![CDATA[Prolonged US Blockade Of Iran Ports Risks Drug Shortages, Wider Supply Chain Woes]]>premium

      
]]> https://feeds.feedblitz.com/~/953876114/0/scrip~Prolonged-US-Blockade-Of-Iran-Ports-Risks-Drug-Shortages-Wider-Supply-Chain-Woes/https://insights.citeline.com/scrip/business/supply-chain/prolonged-us-blockade-of-iran-ports-risks-drug-shortages-wider-supply-chain-woes-SEMZ4LNEPVA63KV7XAUFT6VCJY/
      
]]> Thu, 16 Apr 2026 07:02:12 +0000 https://insights.citeline.com/scrip/podcasts/japan-q1-roundup-podcast-iran-war-impact-divestments-product-approvals-CXMY6RK6PRCV5MZBXTBTQQ2BEE/<![CDATA[Japan Q1 Roundup Podcast: Iran War Impact, Divestments, Product Approvals]]>free

      
]]> https://feeds.feedblitz.com/~/953925686/0/scrip~Japan-Q-Roundup-Podcast-Iran-War-Impact-Divestments-Product-Approvals/https://insights.citeline.com/scrip/podcasts/japan-q1-roundup-podcast-iran-war-impact-divestments-product-approvals-CXMY6RK6PRCV5MZBXTBTQQ2BEE/
      
]]> Fri, 17 Apr 2026 02:59:50 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/freya-lines-up-fb301-phase-ii-push-after-promising-early-stage-data-2GYLRW5ONBF57FHYAXSCCHO5X4/<![CDATA[Freya Lines Up FB301 Phase II Push After Promising Early Stage Data]]>premium

      
]]> https://feeds.feedblitz.com/~/953937110/0/scrip~Freya-Lines-Up-FB-Phase-II-Push-After-Promising-Early-Stage-Data/https://insights.citeline.com/scrip/r-and-d/clinical-trials/freya-lines-up-fb301-phase-ii-push-after-promising-early-stage-data-2GYLRW5ONBF57FHYAXSCCHO5X4/
      
]]> Fri, 17 Apr 2026 08:59:18 +0000 https://insights.citeline.com/scrip/r-and-d/clinical-trials/lilly-to-head-to-fda-after-demonstrating-foundayos-cardiovascular-liver-safety-PRUP4NN6ZZD3HJ5D6OGPBY3LME/<![CDATA[Lilly To Head To FDA After Demonstrating Foundayo’s Cardiovascular, Liver Safety]]>premium

      
]]> https://feeds.feedblitz.com/~/953913566/0/scrip~Lilly-To-Head-To-FDA-After-Demonstrating-Foundayo%e2%80%99s-Cardiovascular-Liver-Safety/https://insights.citeline.com/scrip/r-and-d/clinical-trials/lilly-to-head-to-fda-after-demonstrating-foundayos-cardiovascular-liver-safety-PRUP4NN6ZZD3HJ5D6OGPBY3LME/
      
]]> Thu, 16 Apr 2026 20:25:35 +0000 https://insights.citeline.com/scrip/digital-technologies/ai/pharma-gains-a-seat-at-the-ai-table-as-anthropic-taps-novartiss-narasimhan-OC27XEDICFHQZJJYUXNULFE5IY/<![CDATA[Pharma Gains A Seat At The AI Table As Anthropic Taps Novartis’s Narasimhan]]>premium

      
]]> https://feeds.feedblitz.com/~/953890721/0/scrip~Pharma-Gains-A-Seat-At-The-AI-Table-As-Anthropic-Taps-Novartis%e2%80%99s-Narasimhan/https://insights.citeline.com/scrip/digital-technologies/ai/pharma-gains-a-seat-at-the-ai-table-as-anthropic-taps-novartiss-narasimhan-OC27XEDICFHQZJJYUXNULFE5IY/
      
]]> Thu, 16 Apr 2026 13:07:50 +0000 https://insights.citeline.com/scrip/business/strategy/diamyd-down-in-the-dumps-after-diabetes-drug-fail-HXQSUJWZYZACNIVEL5P74WNFS4/<![CDATA[Diamyd Down In The Dumps After Diabetes Drug Fail]]>premium

      
]]> https://feeds.feedblitz.com/~/953895404/0/scrip~Diamyd-Down-In-The-Dumps-After-Diabetes-Drug-Fail/https://insights.citeline.com/scrip/business/strategy/diamyd-down-in-the-dumps-after-diabetes-drug-fail-HXQSUJWZYZACNIVEL5P74WNFS4/
      
]]> Thu, 16 Apr 2026 13:40:29 +0000 https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-ailux-gets-a-new-cso-from-astrazeneca-Z4BVITZIDNE7PBBOZDCCAQMKWI/<![CDATA[Executives On The Move: Ailux Gets A New CSO From AstraZeneca]]>premium

      
]]> https://feeds.feedblitz.com/~/953894600/0/scrip~Executives-On-The-Move-Ailux-Gets-A-New-CSO-From-AstraZeneca/https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-ailux-gets-a-new-cso-from-astrazeneca-Z4BVITZIDNE7PBBOZDCCAQMKWI/
      
]]> Thu, 16 Apr 2026 13:29:04 +0000 https://insights.citeline.com/scrip/business/financing/storm-raises-56m-to-take-rna-modification-inhibitor-into-phase-ii-SIJQ3UU2YZF7ZN23MREF36EKDA/<![CDATA[Storm Raises $56m To Take RNA Modification Inhibitor Into Phase II]]>premium

      
]]> https://feeds.feedblitz.com/~/953903138/0/scrip~Storm-Raises-m-To-Take-RNA-Modification-Inhibitor-Into-Phase-II/https://insights.citeline.com/scrip/business/financing/storm-raises-56m-to-take-rna-modification-inhibitor-into-phase-ii-SIJQ3UU2YZF7ZN23MREF36EKDA/
      
]]> Thu, 16 Apr 2026 15:59:28 +0000 https://insights.citeline.com/scrip/business/financing/dd-pharmatech-raises-154m-to-progress-mash-core-assets-XD6EZWLU2VF4XIOFEW26QTT7WU/<![CDATA[D&D Pharmatech Raises $154m To Progress MASH, Core Assets]]>premium

      
]]> https://feeds.feedblitz.com/~/953878040/0/scrip~DD-Pharmatech-Raises-m-To-Progress-MASH-Core-Assets/https://insights.citeline.com/scrip/business/financing/dd-pharmatech-raises-154m-to-progress-mash-core-assets-XD6EZWLU2VF4XIOFEW26QTT7WU/
      
]]> Thu, 16 Apr 2026 07:49:51 +0000 https://insights.citeline.com/scrip/business/start-ups-and-smes/biopharma-mid-cap-investors-on-a-yo-yo-diet-in-q1-BVJQ5BYFKZDJ5AEY52B6QEI6QE/<![CDATA[Biopharma Mid-Cap Investors On A Yo-Yo Diet In Q1]]>premium

      
]]> https://feeds.feedblitz.com/~/953844734/0/scrip~Biopharma-MidCap-Investors-On-A-YoYo-Diet-In-Q/https://insights.citeline.com/scrip/business/start-ups-and-smes/biopharma-mid-cap-investors-on-a-yo-yo-diet-in-q1-BVJQ5BYFKZDJ5AEY52B6QEI6QE/
      
]]> Wed, 15 Apr 2026 16:41:47 +0000 https://insights.citeline.com/scrip/therapeutic-category/immunological/bmsbain-300m-venture-emerges-as-beeline-with-lead-asset-nearing-pivotal-stage-SFEY2R3ONZGCLDER2SV73PTB7A/<![CDATA[BMS/Bain $300m Venture Emerges As Beeline With Lead Asset Nearing Pivotal Stage]]>premium

      
]]> https://feeds.feedblitz.com/~/953826497/0/scrip~BMSBain-m-Venture-Emerges-As-Beeline-With-Lead-Asset-Nearing-Pivotal-Stage/https://insights.citeline.com/scrip/therapeutic-category/immunological/bmsbain-300m-venture-emerges-as-beeline-with-lead-asset-nearing-pivotal-stage-SFEY2R3ONZGCLDER2SV73PTB7A/
      
]]> Wed, 15 Apr 2026 11:09:16 +0000 https://insights.citeline.com/scrip/leadership/interviews/poolbeg-well-placed-to-calm-the-cytokine-storm-2UNEWCF7NBFB5OYLE2HSSKSSK4/<![CDATA[Poolbeg Well Placed To Calm The Cytokine Storm ]]>premium

      
]]> https://feeds.feedblitz.com/~/953842166/0/scrip~Poolbeg-Well-Placed-To-Calm-The-Cytokine-Storm/https://insights.citeline.com/scrip/leadership/interviews/poolbeg-well-placed-to-calm-the-cytokine-storm-2UNEWCF7NBFB5OYLE2HSSKSSK4/
      
]]> Wed, 15 Apr 2026 15:31:14 +0000 https://insights.citeline.com/scrip/business/financing/revolutions-strong-data-garner-an-upsized-investor-response-7VI33EIWDBEKHKGYXXQ4XILH7I/<![CDATA[Revolution’s Strong Data Garner An Upsized Investor Response]]>premium

      
]]> https://feeds.feedblitz.com/~/953852003/0/scrip~Revolution%e2%80%99s-Strong-Data-Garner-An-Upsized-Investor-Response/https://insights.citeline.com/scrip/business/financing/revolutions-strong-data-garner-an-upsized-investor-response-7VI33EIWDBEKHKGYXXQ4XILH7I/
      
]]> Wed, 15 Apr 2026 19:39:28 +0000 https://insights.citeline.com/scrip/business/deals/jazz-talks-deals-amid-business-strategy-evolution-6CFWLLQ52BEIZGO6NGG6E5YTBY/<![CDATA[Jazz Talks Deals Amid Business Strategy Evolution]]>premium

      
]]> https://feeds.feedblitz.com/~/953852000/0/scrip~Jazz-Talks-Deals-Amid-Business-Strategy-Evolution/https://insights.citeline.com/scrip/business/deals/jazz-talks-deals-amid-business-strategy-evolution-6CFWLLQ52BEIZGO6NGG6E5YTBY/
      
]]> Wed, 15 Apr 2026 19:41:25 +0000